Wide variation in EU antibiotic use

4 June 2006

The Journal of Antimicrobial Chemotherapy has published a study of antibiotic use in Europe aggregated at the national level over a five-year period (1997-2002). The study's authors gathered consumption data of antibiotics, which were collected and expressed in defined daily doses per 1,000 inhabitants per day. Data for 2002 were available for 15 European countries, and six-year trends for 10 nations. A comparison with ambulatory care consumption data was made for 14 countries.

In 2002, the study found that median national hospital antibiotic consumption in Europe was 2.1 DDD/1,000 inhabitants/day in Europe. This varied from 3.9 in Finland and France to 1.3 in Norway and Sweden. Hospital care consumption as a proportion of total antibiotic consumption ranged from 17.8% to 6.4%. The consumption of hospital-specific antibiotics ranged from 0.43 DDD/1,000 inhabitants/day in Greece and 0.08 in Sweden. Six-year trends in consumption were stable, except for market penetration of new antibiotics in some countries.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight